Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1-(2-(2-chlorobenzoyl)-4-chlorophenyl)-5-glycylaminomethyl-3-dimethylaminocarbonyl-1h-1,2,4-triazole Hydrochloride
2. 450191-s
3. Rilmazafone
4. S 450191
5. S-450191
1. 85815-37-8
2. Rilmazafone Hcl
3. 25t258x8bv
4. 450191-s
5. 5-[[(2-aminoacetyl)amino]methyl]-1-[4-chloro-2-(2-chlorobenzoyl)phenyl]-n,n-dimethyl-1,2,4-triazole-3-carboxamide;hydrochloride
6. Unii-25t258x8bv
7. Ccris 1929
8. Rilmazafone Hydrochloride [jan]
9. Rilmazafonehydrochloride
10. 450191s
11. Schembl409409
12. Dtxsid80235095
13. Hy-u00228
14. Cs-7384
15. Rilmazafone Hydrochloride [mart.]
16. 1h-1,2,4-triazole-3-carboxamide, 5-(((aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-n,n-dimethyl-, Monohydrochloride, Dihydrate
17. Rilmazafone Hydrochloride [who-dd]
18. Rilmazafone Hydrochloride Anhydrous
19. Q27253998
20. 5-(((2-aminoacetyl)amino)methyl)-1-(4-chloro-2-(2-chlorobenzoyl)phenyl)-n,n-dimethyl-1h-1,2,4-triazole-3-carboxamide Hydrochloride
| Molecular Weight | 511.8 g/mol |
|---|---|
| Molecular Formula | C21H21Cl3N6O3 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 7 |
| Exact Mass | 510.074072 g/mol |
| Monoisotopic Mass | 510.074072 g/mol |
| Topological Polar Surface Area | 123 Ų |
| Heavy Atom Count | 33 |
| Formal Charge | 0 |
| Complexity | 696 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Hypnotics and Sedatives
Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)
ABOUT THIS PAGE
A Rilmazafone Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rilmazafone Hydrochloride, including repackagers and relabelers. The FDA regulates Rilmazafone Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rilmazafone Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Rilmazafone Hydrochloride supplier is an individual or a company that provides Rilmazafone Hydrochloride active pharmaceutical ingredient (API) or Rilmazafone Hydrochloride finished formulations upon request. The Rilmazafone Hydrochloride suppliers may include Rilmazafone Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Rilmazafone Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Rilmazafone Hydrochloride Drug Master File in Japan (Rilmazafone Hydrochloride JDMF) empowers Rilmazafone Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Rilmazafone Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Rilmazafone Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Rilmazafone Hydrochloride suppliers with JDMF on PharmaCompass.
Rilmazafone Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rilmazafone Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rilmazafone Hydrochloride GMP manufacturer or Rilmazafone Hydrochloride GMP API supplier for your needs.
A Rilmazafone Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Rilmazafone Hydrochloride's compliance with Rilmazafone Hydrochloride specifications and serves as a tool for batch-level quality control.
Rilmazafone Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Rilmazafone Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rilmazafone Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Rilmazafone Hydrochloride EP), Rilmazafone Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rilmazafone Hydrochloride USP).
LOOKING FOR A SUPPLIER?
